• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马尔堡病毒病:临床医生须知。

Marburg virus disease: A summary for clinicians.

机构信息

University of Nebraska Medical Center, Omaha, NE, USA.

Bellevue Hospital Center, New York, NY, USA.

出版信息

Int J Infect Dis. 2020 Oct;99:233-242. doi: 10.1016/j.ijid.2020.07.042. Epub 2020 Aug 3.

DOI:10.1016/j.ijid.2020.07.042
PMID:32758690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7397931/
Abstract

OBJECTIVES

This article summarizes the countermeasures for Marburg virus disease, focusing on pathogenesis, clinical features and diagnostics. There is an emphasis on therapies and vaccines that have demonstrated, through their evaluation in nonhuman primates (NHPs) and/or in humans, potential for use in an emergency situation.

METHODS

A standardized literature review was conducted on vaccines and treatments for Marburg virus disease, with a focus on human and nonhuman primate data published in the last five years. More detail on the methods that were used is summarized in a companion methods paper.

RESULTS

The study identified six treatments and four vaccine platforms that have demonstrated, through their efficacy in NHPs, potential benefit for treating or preventing infection in humans.

CONCLUSION

Succinct summaries of Marburg countermeasures are provided to give the busy clinician a head start in reviewing the literature if faced with a patient with Marburg virus disease. Links to other authoritative sources of information are also provided.

摘要

目的

本文总结了马尔堡病毒病的对策,重点介绍了发病机制、临床特征和诊断。强调了通过在非人类灵长类动物(NHPs)和/或人类中进行评估,显示出在紧急情况下可能使用的疗法和疫苗。

方法

对马尔堡病毒病的疫苗和治疗方法进行了标准化文献回顾,重点关注过去五年中在人和非人类灵长类动物中发表的数据。在一份配套的方法文件中总结了更详细的方法信息。

结果

该研究确定了六种治疗方法和四种疫苗平台,它们在 NHP 中的疗效表明对人类感染的治疗或预防具有潜在益处。

结论

如果临床医生遇到马尔堡病毒病患者,本文提供了简明的马尔堡对策摘要,以便他们快速查阅文献。还提供了其他权威信息来源的链接。

相似文献

1
Marburg virus disease: A summary for clinicians.马尔堡病毒病:临床医生须知。
Int J Infect Dis. 2020 Oct;99:233-242. doi: 10.1016/j.ijid.2020.07.042. Epub 2020 Aug 3.
2
Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.埃博拉病毒和马尔堡病毒感染非人灵长类动物模型使用中的注意事项。
J Infect Dis. 2015 Oct 1;212 Suppl 2(Suppl 2):S91-7. doi: 10.1093/infdis/jiv284. Epub 2015 Jun 10.
3
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.单次注射疫苗可保护非人灵长类动物免受马尔堡病毒和三种埃博拉病毒的感染。
J Virol. 2009 Jul;83(14):7296-304. doi: 10.1128/JVI.00561-09. Epub 2009 Apr 22.
4
Ebola and Marburg virus vaccines.埃博拉病毒和马尔堡病毒疫苗。
Virus Genes. 2017 Aug;53(4):501-515. doi: 10.1007/s11262-017-1455-x. Epub 2017 Apr 26.
5
Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.单价三价囊泡疫苗可保护猕猴免受致命埃博拉病毒和马尔堡病毒的挑战。
J Virol. 2018 Jan 17;92(3). doi: 10.1128/JVI.01190-17. Print 2018 Feb 1.
6
Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.重组蛋白丝状病毒疫苗可保护食蟹猴免受埃博拉、苏丹和马尔堡病毒的感染。
Front Immunol. 2021 Aug 18;12:703986. doi: 10.3389/fimmu.2021.703986. eCollection 2021.
7
Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease.单次剂量的基于 VSV 的疫苗可迅速保护猕猴免受马尔堡病毒病的侵害。
Front Immunol. 2021 Oct 27;12:774026. doi: 10.3389/fimmu.2021.774026. eCollection 2021.
8
Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques.重组水疱性口炎病毒载体马尔堡疫苗在食蟹猴中的功效和免疫原性。
Viruses. 2024 Jul 24;16(8):1181. doi: 10.3390/v16081181.
9
Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.埃博拉病毒和马尔堡病毒疫苗:最新进展和有前途的候选疫苗。
Hum Vaccin Immunother. 2019;15(10):2359-2377. doi: 10.1080/21645515.2019.1651140. Epub 2019 Oct 7.
10
Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.基于重组水疱性口炎病毒的埃博拉和马尔堡病毒感染疫苗。
J Infect Dis. 2011 Nov;204 Suppl 3(Suppl 3):S1075-81. doi: 10.1093/infdis/jir349.

引用本文的文献

1
A broadly neutralizing antibody recognizes a unique epitope with a signature motif common across coronaviruses.一种广泛中和抗体识别出一个独特的表位,该表位具有冠状病毒共有的特征基序。
Nat Commun. 2025 Aug 15;16(1):7580. doi: 10.1038/s41467-025-63101-1.
2
Immunogenicity of differentially glycosylated Marburg virus glycoproteins expressed in mammalian and insect cells.在哺乳动物细胞和昆虫细胞中表达的差异糖基化马尔堡病毒糖蛋白的免疫原性。
Virol J. 2025 Aug 11;22(1):275. doi: 10.1186/s12985-025-02884-7.
3
Thirteen-Year Sequelae of Marburg Virus Disease Survival: Persistent Cardiometabolic, Immunometabolic, and Haematological Alterations in the Absence of Psychological Morbidity.马尔堡病毒病幸存者的13年后遗症:无心理疾病情况下持续存在的心脏代谢、免疫代谢和血液学改变
Pathogens. 2025 Jul 9;14(7):678. doi: 10.3390/pathogens14070678.
4
Preparedness and Response Considerations for High-Consequence Infectious Disease.高后果传染病的防范与应对考量
Emerg Infect Dis. 2025 Aug;31(8):1507-1515. doi: 10.3201/eid3108.250313.
5
Nipah virus: a summary for clinicians.尼帕病毒:临床医生摘要
Int J Emerg Med. 2025 Jul 9;18(1):126. doi: 10.1186/s12245-025-00916-1.
6
Marburg virus disease: Emerging threat, pathogenesis, and global public health strategies.马尔堡病毒病:新出现的威胁、发病机制及全球公共卫生策略
World J Virol. 2025 Jun 25;14(2):103576. doi: 10.5501/wjv.v14.i2.103576.
7
Construction of Minigenome Replicon of Nipah Virus and Investigation of Biological Activity.尼帕病毒微型基因组复制子的构建及生物学活性研究
Viruses. 2025 May 15;17(5):707. doi: 10.3390/v17050707.
8
Therapeutic advances in Marburg virus disease: from experimental treatments to vaccine development.马尔堡病毒病的治疗进展:从实验性治疗到疫苗研发
Ann Med Surg (Lond). 2025 Mar 28;87(5):2784-2799. doi: 10.1097/MS9.0000000000003213. eCollection 2025 May.
9
Immunogenicity, Pathogenesis, and Host's Immuno-Responses to Marburg Virus Infection.马尔堡病毒感染的免疫原性、发病机制及宿主免疫反应
Pathogens. 2025 Mar 27;14(4):323. doi: 10.3390/pathogens14040323.
10
Marburg Virus Disease: A Narrative Review.马尔堡病毒病:一篇叙述性综述。
Health Sci Rep. 2025 May 6;8(5):e70669. doi: 10.1002/hsr2.70669. eCollection 2025 May.

本文引用的文献

1
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
2
Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus.瑞德西韦(GS-5734)对感染马尔堡病毒的食蟹猕猴有效。
J Infect Dis. 2020 Nov 9;222(11):1894-1901. doi: 10.1093/infdis/jiaa290.
3
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.埃博拉病毒病治疗的随机、对照试验。
N Engl J Med. 2019 Dec 12;381(24):2293-2303. doi: 10.1056/NEJMoa1910993. Epub 2019 Nov 27.
4
Recent advances in marburgvirus research.马尔堡病毒研究的最新进展。
F1000Res. 2019 May 21;8. doi: 10.12688/f1000research.17573.1. eCollection 2019.
5
Shifting the Paradigm - Applying Universal Standards of Care to Ebola Virus Disease.转变模式——将通用护理标准应用于埃博拉病毒病
N Engl J Med. 2019 Apr 11;380(15):1389-1391. doi: 10.1056/NEJMp1817070.
6
Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational Study.实验室发现、同情使用法匹拉韦和 2015 年几内亚埃博拉病毒病患者的结局:一项回顾性观察研究。
J Infect Dis. 2019 Jun 19;220(2):195-202. doi: 10.1093/infdis/jiz078.
7
Persistent Marburg Virus Infection in the Testes of Nonhuman Primate Survivors.恒河猴幸存者睾丸中持续性马尔堡病毒感染。
Cell Host Microbe. 2018 Sep 12;24(3):405-416.e3. doi: 10.1016/j.chom.2018.08.003. Epub 2018 Aug 30.
8
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates.囊膜泡状口炎病毒载体对感染高剂量和低剂量安哥拉马尔堡病毒变异株的非人灵长类动物的暴露后疗效。
J Infect Dis. 2018 Nov 22;218(suppl_5):S582-S587. doi: 10.1093/infdis/jiy293.
9
Post-exposure treatments for Ebola and Marburg virus infections.埃博拉病毒和马尔堡病毒感染的暴露后治疗。
Nat Rev Drug Discov. 2018 Jun;17(6):413-434. doi: 10.1038/nrd.2017.251. Epub 2018 Jan 29.
10
Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus.法匹拉韦(T-705)对感染埃博拉病毒或马尔堡病毒的非人灵长类动物的疗效。
Antiviral Res. 2018 Mar;151:97-104. doi: 10.1016/j.antiviral.2017.12.021. Epub 2017 Dec 28.